Biomarin Pharmaceutical Gross Profit (Quarterly) Trends

Biomarin Pharmaceutical Inc (BMRN)

81.00 -0.72 (-0.88%) USD | NASDAQ | May 10, 16:00

81.00 0.00 (0.00%) After-Hours: 20:00

Gross Profit (Quarterly) Chart

Historical Gross Profit (Quarterly) Data

View and export this data back to 1999. Upgrade now.

Date	Value
March 31, 2024	523.65M
December 31, 2023	510.73M
September 30, 2023	456.58M
June 30, 2023	467.19M
March 31, 2023	460.94M
December 31, 2022	410.25M
September 30, 2022	389.06M
June 30, 2022	410.67M
March 31, 2022	402.39M
December 31, 2021	330.06M
September 30, 2021	305.20M
June 30, 2021	374.63M
March 31, 2021	365.86M
December 31, 2020	325.98M
September 30, 2020	287.99M
June 30, 2020	331.52M
March 31, 2020	390.67M
December 31, 2019	358.54M
September 30, 2019	364.15M
June 30, 2019	310.33M
March 31, 2019	311.56M
December 31, 2018	278.24M
September 30, 2018	312.81M
June 30, 2018	293.83M
March 31, 2018	291.11M

Date	Value
December 31, 2017	282.31M
September 30, 2017	274.67M
June 30, 2017	261.14M
March 31, 2017	253.74M
December 31, 2016	235.94M
September 30, 2016	229.16M
June 30, 2016	248.51M
March 31, 2016	193.62M
December 31, 2015	179.89M
September 30, 2015	174.00M
June 30, 2015	212.07M
March 31, 2015	171.92M
December 31, 2014	191.75M
September 30, 2014	146.63M
June 30, 2014	160.58M
March 31, 2014	128.74M
December 31, 2013	129.60M
September 30, 2013	108.82M
June 30, 2013	114.24M
March 31, 2013	107.43M
December 31, 2012	105.41M
September 30, 2012	103.50M
June 30, 2012	100.44M
March 31, 2012	99.54M
December 31, 2011	86.33M

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Quarterly) Range, Past 5 Years

287.99M

Minimum

Sep 2020

523.65M

Maximum

Mar 2024

388.82M

Average

381.84M

Median

Gross Profit (Quarterly) Benchmarks